IL-6 regulates epithelial ovarian cancer EMT, invasion, and metastasis by modulating Let-7c and miR-200c through the STAT3/HIF-1α pathway

Interleukin-6 (IL-6) and hypoxia-inducible factor-1α (HIF-1α) play important roles in epithelial-mesenchymal transformation (EMT) and tumor development. Previous studies have demonstrated that IL-6 promotes EMT, invasion, and metastasis in epithelial ovarian cancer (EOC) cells by activating the STAT...

Full description

Saved in:
Bibliographic Details
Published inMedical oncology (Northwood, London, England) Vol. 41; no. 6; p. 155
Main Authors Guo, Qiao Yun, Song, Jiang Nan, Chen, Yu Meng, Yuan, Hai Ning, Xue, Wen Shu, Sun, Yang, Niu, Xiu long, Wang, Yue, Chen, Xiao
Format Journal Article
LanguageEnglish
Published New York Springer US 14.05.2024
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Interleukin-6 (IL-6) and hypoxia-inducible factor-1α (HIF-1α) play important roles in epithelial-mesenchymal transformation (EMT) and tumor development. Previous studies have demonstrated that IL-6 promotes EMT, invasion, and metastasis in epithelial ovarian cancer (EOC) cells by activating the STAT3/HIF-1α pathway. MicroRNA (miRNA) is non-coding small RNAs that also play an important role in tumor development. Notably, Let-7 and miR-200 families are prominently altered in EOC. However, whether IL-6 regulates the expression of Let-7 and miR-200 families through the STAT3/HIF-1α signaling to induce EMT in EOC remains poorly understood. In this study, we conducted in vitro and in vivo investigations using two EOC cell lines, SKOV3, and OVCAR3 cells. Our findings demonstrate that IL-6 down-regulates the mRNA levels of Let-7c and miR-200c while up-regulating their target genes HMGA2 and ZEB1 through the STAT3/HIF-1α signaling in EOC cells and in vivo. Additionally, to explore the regulatory role of HIF-1α on miRNAs, both exogenous HIF blockers YC-1 and endogenous high expression or inhibition of HIF-1α can be utilized. Both approaches can confirm that the downstream molecule HIF-1α inhibits the expression and function of Let-7c and miR-200c. Further mechanistic research revealed that the overexpression of Let-7c or miR-200c can reverse the malignant evolution of EOC cells induced by IL-6, including EMT, invasion, and metastasis. Consequently, our results suggest that IL-6 regulates the expression of Let-7c and miR-200c through the STAT3/HIF-1α pathway, thereby promoting EMT, invasion, and metastasis in EOC cells.
AbstractList Interleukin-6 (IL-6) and hypoxia-inducible factor-1α (HIF-1α) play important roles in epithelial-mesenchymal transformation (EMT) and tumor development. Previous studies have demonstrated that IL-6 promotes EMT, invasion, and metastasis in epithelial ovarian cancer (EOC) cells by activating the STAT3/HIF-1α pathway. MicroRNA (miRNA) is non-coding small RNAs that also play an important role in tumor development. Notably, Let-7 and miR-200 families are prominently altered in EOC. However, whether IL-6 regulates the expression of Let-7 and miR-200 families through the STAT3/HIF-1α signaling to induce EMT in EOC remains poorly understood. In this study, we conducted in vitro and in vivo investigations using two EOC cell lines, SKOV3, and OVCAR3 cells. Our findings demonstrate that IL-6 down-regulates the mRNA levels of Let-7c and miR-200c while up-regulating their target genes HMGA2 and ZEB1 through the STAT3/HIF-1α signaling in EOC cells and in vivo. Additionally, to explore the regulatory role of HIF-1α on miRNAs, both exogenous HIF blockers YC-1 and endogenous high expression or inhibition of HIF-1α can be utilized. Both approaches can confirm that the downstream molecule HIF-1α inhibits the expression and function of Let-7c and miR-200c. Further mechanistic research revealed that the overexpression of Let-7c or miR-200c can reverse the malignant evolution of EOC cells induced by IL-6, including EMT, invasion, and metastasis. Consequently, our results suggest that IL-6 regulates the expression of Let-7c and miR-200c through the STAT3/HIF-1α pathway, thereby promoting EMT, invasion, and metastasis in EOC cells.
Interleukin-6 (IL-6) and hypoxia-inducible factor-1α (HIF-1α) play important roles in epithelial-mesenchymal transformation (EMT) and tumor development. Previous studies have demonstrated that IL-6 promotes EMT, invasion, and metastasis in epithelial ovarian cancer (EOC) cells by activating the STAT3/HIF-1α pathway. MicroRNA (miRNA) is non-coding small RNAs that also play an important role in tumor development. Notably, Let-7 and miR-200 families are prominently altered in EOC. However, whether IL-6 regulates the expression of Let-7 and miR-200 families through the STAT3/HIF-1α signaling to induce EMT in EOC remains poorly understood. In this study, we conducted in vitro and in vivo investigations using two EOC cell lines, SKOV3, and OVCAR3 cells. Our findings demonstrate that IL-6 down-regulates the mRNA levels of Let-7c and miR-200c while up-regulating their target genes HMGA2 and ZEB1 through the STAT3/HIF-1α signaling in EOC cells and in vivo. Additionally, to explore the regulatory role of HIF-1α on miRNAs, both exogenous HIF blockers YC-1 and endogenous high expression or inhibition of HIF-1α can be utilized. Both approaches can confirm that the downstream molecule HIF-1α inhibits the expression and function of Let-7c and miR-200c. Further mechanistic research revealed that the overexpression of Let-7c or miR-200c can reverse the malignant evolution of EOC cells induced by IL-6, including EMT, invasion, and metastasis. Consequently, our results suggest that IL-6 regulates the expression of Let-7c and miR-200c through the STAT3/HIF-1α pathway, thereby promoting EMT, invasion, and metastasis in EOC cells.Interleukin-6 (IL-6) and hypoxia-inducible factor-1α (HIF-1α) play important roles in epithelial-mesenchymal transformation (EMT) and tumor development. Previous studies have demonstrated that IL-6 promotes EMT, invasion, and metastasis in epithelial ovarian cancer (EOC) cells by activating the STAT3/HIF-1α pathway. MicroRNA (miRNA) is non-coding small RNAs that also play an important role in tumor development. Notably, Let-7 and miR-200 families are prominently altered in EOC. However, whether IL-6 regulates the expression of Let-7 and miR-200 families through the STAT3/HIF-1α signaling to induce EMT in EOC remains poorly understood. In this study, we conducted in vitro and in vivo investigations using two EOC cell lines, SKOV3, and OVCAR3 cells. Our findings demonstrate that IL-6 down-regulates the mRNA levels of Let-7c and miR-200c while up-regulating their target genes HMGA2 and ZEB1 through the STAT3/HIF-1α signaling in EOC cells and in vivo. Additionally, to explore the regulatory role of HIF-1α on miRNAs, both exogenous HIF blockers YC-1 and endogenous high expression or inhibition of HIF-1α can be utilized. Both approaches can confirm that the downstream molecule HIF-1α inhibits the expression and function of Let-7c and miR-200c. Further mechanistic research revealed that the overexpression of Let-7c or miR-200c can reverse the malignant evolution of EOC cells induced by IL-6, including EMT, invasion, and metastasis. Consequently, our results suggest that IL-6 regulates the expression of Let-7c and miR-200c through the STAT3/HIF-1α pathway, thereby promoting EMT, invasion, and metastasis in EOC cells.
ArticleNumber 155
Author Guo, Qiao Yun
Wang, Yue
Chen, Yu Meng
Yuan, Hai Ning
Sun, Yang
Niu, Xiu long
Xue, Wen Shu
Chen, Xiao
Song, Jiang Nan
Author_xml – sequence: 1
  givenname: Qiao Yun
  surname: Guo
  fullname: Guo, Qiao Yun
  organization: School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, School of Pharmacy and Biological Technology, Tianjin Medical College
– sequence: 2
  givenname: Jiang Nan
  surname: Song
  fullname: Song, Jiang Nan
  organization: Department of Gynaecology and Obstetrics, Characteristic Medical Center of Chinese People’s Armed Police Force, Department of Gynecology and Obstetrics, Chinese People’s Liberation Army General Hospital
– sequence: 3
  givenname: Yu Meng
  surname: Chen
  fullname: Chen, Yu Meng
  organization: College of Pharmacy, China Pharmaceutical University
– sequence: 4
  givenname: Hai Ning
  surname: Yuan
  fullname: Yuan, Hai Ning
  organization: School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine
– sequence: 5
  givenname: Wen Shu
  surname: Xue
  fullname: Xue, Wen Shu
  organization: School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine
– sequence: 6
  givenname: Yang
  surname: Sun
  fullname: Sun, Yang
  organization: Department of Gynaecology and Obstetrics, Characteristic Medical Center of Chinese People’s Armed Police Force
– sequence: 7
  givenname: Xiu long
  surname: Niu
  fullname: Niu, Xiu long
  organization: Institute of Prevention and Treatment of Dermatosis in Alpine Environment of Plateau, Characteristic Medical Center of Chinese People’s Armed Police Force
– sequence: 8
  givenname: Yue
  surname: Wang
  fullname: Wang, Yue
  email: wangyue6806@tjutcm.edu.cn
  organization: School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine
– sequence: 9
  givenname: Xiao
  surname: Chen
  fullname: Chen, Xiao
  organization: Department of Gynaecology and Obstetrics, Characteristic Medical Center of Chinese People’s Armed Police Force
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38744773$$D View this record in MEDLINE/PubMed
BookMark eNp9kd1qHCEYhqWkNH-9gR4UoSc9iI0_M-ochpA0C1sKzQZyJuo4u4YZ3epMyt5C76Y30muq20l_6EFB-QQfHz99j8FBiMEB8IrgdwRjcZ4JxYwiTKsyGZWIPgNHpK4bRBi5P_hrfQiOc37AmJKaNi_AIZOiqoRgR-DrYok4TG499Xp0GbqtHzeu97qH8VEnrwO0OliX4NWH1Rn04VFnH8MZ1KGFgxt1LsNnaHZwiO1e4sMaLt2IhJ0Z_wlRjC0cNylO602pDt6uLlbs_GZxjcj3b3Crx80XvTsFzzvdZ_fyqZ6Au-ur1eUNWn58v7i8WCLLKC9eLpi2vMVatOX5XW2IYZ2RjBnccWltYzpjXdtgzVqBXSekltLwWmrOqvJRJ-Dt7N2m-HlyeVSDz9b1vQ4uTlkxXNdVjUnDCvrmH_QhTimU7vZUxbkUrCoUnSmbYs7JdWqb_KDTThGs9kmpOSlVklI_k1L7Ll4_qSczuPb3kV_RFIDNQC5bYe3Sn7v_o_0BU-ufXA
Cites_doi 10.1002/cac2.12138
10.4161/rna.5.3.6558
10.1016/j.canlet.2015.01.010
10.3389/fphar.2016.00271
10.1016/j.lfs.2017.01.005
10.1016/S1470-2045(11)70123-1
10.4161/cbt.7.1.5458
10.1016/S1995-7645(14)60040-7
10.1016/j.biopha.2020.110037
10.1007/s13277-015-4625-2
10.1038/onc.2012.573
10.4161/cc.7.14.6324
10.1002/jcp.26116
10.1186/1471-2164-14-352
10.1016/j.molcel.2012.01.015
10.1021/pr9007927
10.1038/s41598-018-27184-9
10.3892/or.2014.3022
10.1016/j.yexcr.2017.09.014
10.4149/neo_2014_082
10.1155/2023/8334881
10.31557/APJCP.2021.22.2.407
10.1016/j.hpb.2021.06.421
10.1371/journal.pone.0023752
10.1038/modpathol.2010.49
10.1007/s00109-013-1080-7
10.1007/s00432-010-0898-4
10.1371/journal.pone.0077249
10.1126/science.1137999
10.1007/s00018-018-2941-6
10.1007/s13277-015-3138-3
10.1016/j.ejphar.2020.173817
10.1002/jcp.24593
10.1186/s12964-020-00562-5
10.1016/j.semcancer.2022.03.028
10.1038/sj.bjc.6604794
10.3390/ijms22158334
ContentType Journal Article
Copyright The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Copyright_xml – notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
– notice: 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
K9.
7X8
DOI 10.1007/s12032-024-02328-2
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest Health & Medical Complete (Alumni)
MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1559-131X
ExternalDocumentID 10_1007_s12032_024_02328_2
38744773
Genre Journal Article
GrantInformation_xml – fundername: the Great Program of Science Foundation of Tianjin
  grantid: No. 18JCZDJC33200
– fundername: the National Natural Science Foundation of China
  grantid: No.81572852; 81273520
– fundername: Center Innovation Team Project
  grantid: KYCXTD0502; KYCXTD0203
– fundername: Center Innovation Team Project
  grantid: KYCXTD0203
– fundername: the National Natural Science Foundation of China
  grantid: 81273520
– fundername: Center Innovation Team Project
  grantid: KYCXTD0502
– fundername: the National Natural Science Foundation of China
  grantid: No.81572852
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-~C
.86
.VR
06C
06D
0R~
0VY
203
29M
29~
2J2
2JN
2JY
2KG
2KM
2LR
2~H
30V
4.4
406
408
40E
53G
5GY
5RE
5VS
6NX
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAFGU
AAHNG
AAIAL
AAJBT
AAJKR
AANZL
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAWTL
AAYIU
AAYQN
ABAKF
ABDZT
ABECU
ABFGW
ABFTV
ABHQN
ABIPD
ABJNI
ABJOX
ABKAS
ABKCH
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABWNU
ABXPI
ACAOD
ACBMV
ACBRV
ACBYP
ACCUX
ACDTI
ACGFS
ACHSB
ACHVE
ACHXU
ACIGE
ACIPQ
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACTTH
ACVWB
ACWMK
ACZOJ
ADBBV
ADHHG
ADHIR
ADINQ
ADJJI
ADKNI
ADKPE
ADMDM
ADOXG
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEFQL
AEFTE
AEGAL
AEGNC
AEJHL
AEJRE
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AESTI
AETLH
AEVLU
AEVTX
AEXYK
AFBBN
AFLOW
AFNRJ
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGBP
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHMBA
AHSBF
AIAKS
AIGIU
AIIXL
AILAN
AIMYW
AITGF
AJDOV
AJRNO
AJZVZ
AKMHD
AKQUC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
AXYYD
B-.
BA0
BENPR
BGNMA
CS3
CSCUP
DDRTE
DNIVK
DPUIP
DU5
EBLON
EBS
EIOEI
EJD
ESBYG
F5P
FERAY
FFXSO
FIGPU
FNLPD
FRRFC
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
HF~
HG6
HMJXF
HRMNR
HZ~
IJ-
IKXTQ
IMOTQ
IWAJR
IXD
I~X
I~Z
J-C
J0Z
JBSCW
JZLTJ
KOV
LLZTM
M4Y
MA-
N9A
NF0
NPVJJ
NQJWS
NU0
O93
O9G
O9I
O9J
P19
P9S
PF0
PT4
PT5
PZZ
QOK
QOR
QOS
R89
R9I
RHV
ROL
RPX
RSV
S16
S1Z
S27
S37
S3B
SAP
SDE
SDH
SDM
SHX
SISQX
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SZ9
SZN
T13
TSG
TT1
TUC
U2A
U9L
UG4
UNUBA
UOJIU
UTJUX
VC2
W48
WK8
YLTOR
Z7U
Z82
Z87
Z8O
Z8V
Z91
ZMTXR
ZOVNA
~A9
~EX
AAYZH
CGR
CUY
CVF
ECM
EIF
NPM
SJYHP
AAYXX
CITATION
K9.
7X8
ID FETCH-LOGICAL-c326t-7673ac6d0a7d032f5b1b3fb833b0f68cc9bfbced90a3d70ef78a88b658a634023
IEDL.DBID U2A
ISSN 1559-131X
1357-0560
IngestDate Sat Oct 26 04:38:58 EDT 2024
Thu Oct 10 16:56:34 EDT 2024
Thu Sep 12 18:30:49 EDT 2024
Sat Nov 02 12:29:27 EDT 2024
Sat Jun 15 09:01:22 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Let-7c and miR-200c
Epithelial ovarian cancer (EOC)
IL-6/STAT3/HIF-1α
EMT
Invasion and metastasis
Language English
License 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c326t-7673ac6d0a7d032f5b1b3fb833b0f68cc9bfbced90a3d70ef78a88b658a634023
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 38744773
PQID 3054668734
PQPubID 30753
ParticipantIDs proquest_miscellaneous_3055450193
proquest_journals_3054668734
crossref_primary_10_1007_s12032_024_02328_2
pubmed_primary_38744773
springer_journals_10_1007_s12032_024_02328_2
PublicationCentury 2000
PublicationDate 2024-05-14
PublicationDateYYYYMMDD 2024-05-14
PublicationDate_xml – month: 05
  year: 2024
  text: 2024-05-14
  day: 14
PublicationDecade 2020
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: United States
– name: Middlesex
PublicationTitle Medical oncology (Northwood, London, England)
PublicationTitleAbbrev Med Oncol
PublicationTitleAlternate Med Oncol
PublicationYear 2024
Publisher Springer US
Springer Nature B.V
Publisher_xml – name: Springer US
– name: Springer Nature B.V
References Yang, Wu (CR15) 2008; 7
Garg, Potter, Abrahams (CR35) 2013; 8
Korpal, Kang (CR41) 2008; 5
Yang, Ma, Zhou, Cao, Zhou, Zhang, Zhao, Liu, Fan (CR26) 2019; 76
Shan, Li, Huang (CR27) 2014; 229
Pan, Liu, Shang, Zhou, Yang (CR7) 2021; 41
Gyamfi, Lee, Eom, Choi (CR4) 2018; 8
Mir, Bashir, Jan (CR10) 2023
Mahajan, Liu, Gellert, Zou, Yang, Lee (CR19) 2010; 23
Xi, Xin, Ye (CR21) 2014; 7
Abaurrea, Araujo, Caffarel (CR23) 2021; 22
Shi, Li, Wu, Tang, Chen, Xue (CR20) 2016; 37
Guo, Chen, Shi, Wang, Chen, Diao (CR18) 2013; 32
Nilsson, Dillon, Devakumar, Shi, Greig, Rogers (CR37) 2010; 9
Huang, Chen, Wu, He, Huang, Liu, Wang, Wang (CR24) 2017; 171
Macciò, Madeddu (CR8) 2013; 91
Gao, Wu (CR29) 2015; 36
Zare, Bastami, Solali, Alivand (CR16) 2018; 233
Kang, Cui, Zhang, Yang, Jiang (CR28) 2013; 14
Rokavec, Wu, Luo (CR34) 2012; 45
Xu, Yu, Ma (CR6) 2021; 894
Canale, Foschi, Andreone, Ercolani, Marisi, Conti (CR32) 2022; 24
Tsai, Lin, Wang, Chiu, Chou, Chiu (CR30) 1852; 2015
Yan, Zhang, Fan, Li, Zhou (CR31) 2014; 61
Yuan (CR3) 2011; 40
Zhang, Yang, Sun, Song (CR5) 2023; 2023
Colomiere, Ward, Riley, Trenerry, Cameron-Smith, Findlay (CR11) 2009; 100
Joseph, Conroy, Pavlov, Sontakke, Tomar, Eggens-Meijer (CR14) 2015; 359
Shang, Chen, Ye, Wei, Liu, Wang (CR25) 2017; 360
Sung, Ferlay, Siegel, Laversanne, Soerjomataram, Jemal (CR1) 2020; 71
Kozak, Jonak, Maciejewski (CR38) 2020; 125
Mahmood, Mushtaq, Jamal, Hanif, Akhlaq, Awan (CR17) 2021; 22
Bose, Saha, Chatterjee, Srivastava (CR9) 2022; 86
Cheng, Sun, Wang, Gao, Zhang, Zhou (CR12) 2011; 6
Kim, Cassone, Otvos, Vogiatzi (CR36) 2008; 7
Cooke, Brenton (CR2) 2011; 12
Cheng, Wang, Liu, Liu, Xia, Xu (CR13) 2014; 31
Mayr, Hemann, Bartel (CR33) 2007; 315
Sulaiman, Ab Mutalib, Jamal (CR22) 2016; 7
Li, Shi, Liu (CR40) 2020; 18
Wong, Man, Tsang, Tsao, Tsang, Chan (CR39) 2011; 137
Z Shi (2328_CR20) 2016; 37
A Macciò (2328_CR8) 2013; 91
J Gyamfi (2328_CR4) 2018; 8
W Yang (2328_CR26) 2019; 76
Y Shang (2328_CR25) 2017; 360
F Shan (2328_CR27) 2014; 229
Y Yan (2328_CR31) 2014; 61
M Korpal (2328_CR41) 2008; 5
MA Mir (2328_CR10) 2023
SA Sulaiman (2328_CR22) 2016; 7
SL Cooke (2328_CR2) 2011; 12
CL Nilsson (2328_CR37) 2010; 9
N Mahmood (2328_CR17) 2021; 22
Y Gao (2328_CR29) 2015; 36
G Pan (2328_CR7) 2021; 41
M Garg (2328_CR35) 2013; 8
M Yang (2328_CR15) 2008; 7
A Mahajan (2328_CR19) 2010; 23
L Guo (2328_CR18) 2013; 32
Q Li (2328_CR40) 2020; 18
J Kozak (2328_CR38) 2020; 125
M Zare (2328_CR16) 2018; 233
CX Huang (2328_CR24) 2017; 171
T Zhang (2328_CR5) 2023; 2023
M Canale (2328_CR32) 2022; 24
H Sung (2328_CR1) 2020; 71
T Wong (2328_CR39) 2011; 137
Y Xi (2328_CR21) 2014; 7
M Colomiere (2328_CR11) 2009; 100
S Bose (2328_CR9) 2022; 86
JV Joseph (2328_CR14) 2015; 359
C Tsai (2328_CR30) 1852; 2015
Y Yuan (2328_CR3) 2011; 40
S Xu (2328_CR6) 2021; 894
Z Cheng (2328_CR13) 2014; 31
L Kang (2328_CR28) 2013; 14
M Rokavec (2328_CR34) 2012; 45
C Mayr (2328_CR33) 2007; 315
HL Kim (2328_CR36) 2008; 7
Z Cheng (2328_CR12) 2011; 6
A Abaurrea (2328_CR23) 2021; 22
References_xml – volume: 41
  start-page: 199
  issue: 3
  year: 2021
  end-page: 217
  ident: CR7
  article-title: EMT-associated microRNAs and their roles in cancer stemness and drug resistance
  publication-title: Cancer Commun
  doi: 10.1002/cac2.12138
  contributor:
    fullname: Yang
– volume: 5
  start-page: 115
  issue: 3
  year: 2008
  end-page: 119
  ident: CR41
  article-title: The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis
  publication-title: RNA Biol
  doi: 10.4161/rna.5.3.6558
  contributor:
    fullname: Kang
– volume: 71
  start-page: 209
  issue: 2021
  year: 2020
  end-page: 249
  ident: CR1
  article-title: Global Cancer Statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries
  publication-title: Cancer J. Clin.
  contributor:
    fullname: Jemal
– start-page: 137
  year: 2023
  end-page: 164
  ident: CR10
  publication-title: The role of interleukin (IL)-6/IL-6 receptor axis in cancer, cytokine and chemokine networks in cancer
  contributor:
    fullname: Jan
– volume: 359
  start-page: 107
  year: 2015
  end-page: 116
  ident: CR14
  article-title: Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1α-ZEB1 axis
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2015.01.010
  contributor:
    fullname: Eggens-Meijer
– volume: 7
  start-page: 271
  year: 2016
  ident: CR22
  article-title: Mir-200c regulation of metastases in ovarian cancer: potential role in epithelial and mesenchymal transition
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2016.00271
  contributor:
    fullname: Jamal
– volume: 171
  start-page: 21
  year: 2017
  end-page: 29
  ident: CR24
  article-title: Zebrafish let-7b acts downstream of hypoxia-inducible factor-1α to assist in hypoxia-mediated cell proliferation and cell cycle regulation
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2017.01.005
  contributor:
    fullname: Wang
– volume: 12
  start-page: 1169
  year: 2011
  end-page: 1174
  ident: CR2
  article-title: Evolution of platinum resistance in high-grade serous ovarian cancer
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(11)70123-1
  contributor:
    fullname: Brenton
– volume: 7
  start-page: 10
  issue: 1
  year: 2008
  end-page: 14
  ident: CR36
  article-title: HIF-1α and STAT3 client proteins interacting with the cancer chaperone Hsp90: therapeutic considerations
  publication-title: Cancer Biol Ther
  doi: 10.4161/cbt.7.1.5458
  contributor:
    fullname: Vogiatzi
– volume: 7
  start-page: 289
  year: 2014
  end-page: 292
  ident: CR21
  article-title: Effects of hmga2 on malignant degree, invasion, metastasis, proliferation and cellular morphology of ovarian cancer cells
  publication-title: Asian Pacific J Trop Med
  doi: 10.1016/S1995-7645(14)60040-7
  contributor:
    fullname: Ye
– volume: 125
  year: 2020
  ident: CR38
  article-title: The function of mir-200 family in oxidative stress response evoked in cancer chemotherapy and radiotherapy
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2020.110037
  contributor:
    fullname: Maciejewski
– volume: 37
  start-page: 7515
  year: 2016
  end-page: 7523
  ident: CR20
  article-title: Silencing of hmga2 suppresses cellular proliferation, migration, invasion, and epithelial–mesenchymal transition in bladder cancer
  publication-title: Tumor Biology
  doi: 10.1007/s13277-015-4625-2
  contributor:
    fullname: Xue
– volume: 32
  start-page: 5272
  year: 2013
  end-page: 5282
  ident: CR18
  article-title: Stat3-coordinated lin-28–let-7–hmga2 and mir-200–zeb1 circuits initiate and maintain oncostatin m-driven epithelial–mesenchymal transition
  publication-title: Oncogene
  doi: 10.1038/onc.2012.573
  contributor:
    fullname: Diao
– volume: 7
  start-page: 2090
  year: 2008
  end-page: 2096
  ident: CR15
  article-title: Twist activation by hypoxia inducible factor-1 (hif-1): implications in metastasis and development
  publication-title: Cell Cycle
  doi: 10.4161/cc.7.14.6324
  contributor:
    fullname: Wu
– volume: 233
  start-page: 3729
  year: 2018
  end-page: 3744
  ident: CR16
  article-title: Aberrant mirna promoter methylation and emt-involving mirnas in breast cancer metastasis: diagnosis and therapeutic implications
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.26116
  contributor:
    fullname: Alivand
– volume: 14
  start-page: 352
  year: 2013
  ident: CR28
  article-title: Identification of microRNAs associated with sexual maturity in chicken ovary by illumina small RNA deep sequencing
  publication-title: BMC Genomics
  doi: 10.1186/1471-2164-14-352
  contributor:
    fullname: Jiang
– volume: 45
  start-page: 777
  year: 2012
  end-page: 789
  ident: CR34
  article-title: IL6-mediated suppression of mir-200c directs constitutive activation of inflammatory signaling circuit driving transformation and tumorigenesis
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2012.01.015
  contributor:
    fullname: Luo
– volume: 9
  start-page: 430
  year: 2010
  end-page: 443
  ident: CR37
  article-title: Quantitative phosphoproteomic analysis of the stat3/il-6/hif1α signaling network: an initial study in gsc11 glioblastoma stem cells
  publication-title: J Proteome Res
  doi: 10.1021/pr9007927
  contributor:
    fullname: Rogers
– volume: 8
  start-page: 8859
  year: 2018
  ident: CR4
  article-title: Interleukin-6/stat3 signalling regulates adipocyte induced epithelial-mesenchymal transition in breast cancer cells
  publication-title: Sci Rep
  doi: 10.1038/s41598-018-27184-9
  contributor:
    fullname: Choi
– volume: 31
  start-page: 1891
  year: 2014
  end-page: 1898
  ident: CR13
  article-title: Effects of the hif-1α and NF-κb loop on epithelial-mesenchymal transition and chemoresistance induced by hypoxia in pancreatic cancer cells
  publication-title: Oncol Rep
  doi: 10.3892/or.2014.3022
  contributor:
    fullname: Xu
– volume: 360
  start-page: 243
  year: 2017
  end-page: 256
  ident: CR25
  article-title: Hif-1α/ascl2/mir-200b regulatory feedback circuit modulated the epithelial-mesenchymal transition (EMT) in colorectal cancer cells
  publication-title: Exp Cell Res
  doi: 10.1016/j.yexcr.2017.09.014
  contributor:
    fullname: Wang
– volume: 61
  start-page: 672
  year: 2014
  end-page: 679
  ident: CR31
  article-title: Breast cancer-specific trail expression mediated by miRNA response elements of let-7 and mir-122
  publication-title: Neoplasma
  doi: 10.4149/neo_2014_082
  contributor:
    fullname: Zhou
– volume: 2023
  start-page: 1
  year: 2023
  end-page: 14
  ident: CR5
  article-title: Interleukin-6 and hypoxia synergistically promote EMT-mediated invasion in epithelial ovarian cancer via the IL-6/STAT3/HIF-1α feedback loop
  publication-title: Anal Cell Pathol
  doi: 10.1155/2023/8334881
  contributor:
    fullname: Song
– volume: 22
  start-page: 407
  year: 2021
  ident: CR17
  article-title: Potential utility of cell free high mobility group at-hook 2 (hmga2) as a prognostic biomarker in liquid biopsies of oral squamous cell carcinoma
  publication-title: Asian Pacific J Cancer Prev: APJCP
  doi: 10.31557/APJCP.2021.22.2.407
  contributor:
    fullname: Awan
– volume: 24
  start-page: 244
  year: 2022
  end-page: 254
  ident: CR32
  article-title: Role of circulating microRNAs to predict hepatocellular carcinoma recurrence in patients treated with radiofrequency ablation or surgery
  publication-title: HPB
  doi: 10.1016/j.hpb.2021.06.421
  contributor:
    fullname: Conti
– volume: 6
  year: 2011
  ident: CR12
  article-title: Nuclear factor-κb–dependent epithelial to mesenchymal transition induced by HIF-1α activation in pancreatic cancer cells under hypoxic conditions
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0023752
  contributor:
    fullname: Zhou
– volume: 23
  start-page: 673
  year: 2010
  end-page: 681
  ident: CR19
  article-title: Hmga2: a biomarker significantly overexpressed in high-grade ovarian serous carcinoma
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.2010.49
  contributor:
    fullname: Lee
– volume: 91
  start-page: 1355
  year: 2013
  end-page: 1368
  ident: CR8
  article-title: The role of interleukin-6 in the evolution of ovarian cancer: clinical and prognostic implications-a review
  publication-title: J Mol Med
  doi: 10.1007/s00109-013-1080-7
  contributor:
    fullname: Madeddu
– volume: 137
  start-page: 415
  year: 2011
  end-page: 422
  ident: CR39
  article-title: MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through down regulating c-myc expression
  publication-title: J Cancer Res Clin Oncol
  doi: 10.1007/s00432-010-0898-4
  contributor:
    fullname: Chan
– volume: 8
  year: 2013
  ident: CR35
  article-title: Identification of microRNAs that regulate tlr2-mediated trophoblast apoptosis and inhibition of IL-6 miRNA
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0077249
  contributor:
    fullname: Abrahams
– volume: 315
  start-page: 1576
  year: 2007
  end-page: 1579
  ident: CR33
  article-title: Disrupting the pairing betweenlet-7 and hmga2 enhances oncogenic transformation
  publication-title: Science
  doi: 10.1126/science.1137999
  contributor:
    fullname: Bartel
– volume: 76
  start-page: 453
  issue: 3
  year: 2019
  end-page: 471
  ident: CR26
  article-title: Reciprocal regulations between miRNAs and HIF-1α in human cancers
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-018-2941-6
  contributor:
    fullname: Fan
– volume: 2015
  start-page: 851
  year: 1852
  end-page: 861
  ident: CR30
  article-title: Over-expression of cofilin-1 suppressed growth and invasion of cancer cells is associated with up-regulation of let-7 microRNA
  publication-title: Biochim. Biophys. Acta Mol. Basis Dis.
  contributor:
    fullname: Chiu
– volume: 36
  start-page: 4843
  year: 2015
  end-page: 4850
  ident: CR29
  article-title: Microrna-200c and microrna-141 as potential diagnostic and prognostic biomarkers for ovarian cancer
  publication-title: Tumor Biology
  doi: 10.1007/s13277-015-3138-3
  contributor:
    fullname: Wu
– volume: 894
  year: 2021
  ident: CR6
  article-title: IL-6 promotes nuclear translocation of HIF-1α to aggravate chemoresistance of ovarian cancer cells
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2020.173817
  contributor:
    fullname: Ma
– volume: 229
  start-page: 1511
  issue: 10
  year: 2014
  end-page: 1520
  ident: CR27
  article-title: HIF-1 alpha-induced up-regulation of miR-9 contributes to phenotypic modulation in pulmonary artery smooth muscle cells during hypoxia
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.24593
  contributor:
    fullname: Huang
– volume: 18
  start-page: 108
  year: 2020
  ident: CR40
  article-title: The role of wnt/β-catenin-lin28a/let-7 axis in embryo implantation competency and epithelial-mesenchymal transition (EMT)
  publication-title: Cell Commun Signal
  doi: 10.1186/s12964-020-00562-5
  contributor:
    fullname: Liu
– volume: 40
  start-page: 1171
  year: 2011
  end-page: 1179
  ident: CR3
  article-title: Il-6-induced epithelial-mesenchymal transition promotes the generation of breast cancer stem-like cells analogous to mammosphere cultures
  publication-title: Int J Oncol
  contributor:
    fullname: Yuan
– volume: 86
  start-page: 568
  issue: Pt 2
  year: 2022
  end-page: 579
  ident: CR9
  article-title: Chemokines driven ovarian cancer progression, metastasis and chemoresistance: potential pharmacological targets for cancer therapy
  publication-title: Semin Cancer Biol
  doi: 10.1016/j.semcancer.2022.03.028
  contributor:
    fullname: Srivastava
– volume: 100
  start-page: 134
  year: 2009
  end-page: 144
  ident: CR11
  article-title: Cross talk of signals between EGFR and IL-6 through jak2/stat3 mediate epithelial–mesenchymal transition in ovarian carcinomas
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6604794
  contributor:
    fullname: Findlay
– volume: 22
  start-page: 8334
  issue: 15
  year: 2021
  ident: CR23
  article-title: The role of the IL-6 cytokine family in epithelial-mesenchymal plasticity in cancer progression
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms22158334
  contributor:
    fullname: Caffarel
– volume: 360
  start-page: 243
  year: 2017
  ident: 2328_CR25
  publication-title: Exp Cell Res
  doi: 10.1016/j.yexcr.2017.09.014
  contributor:
    fullname: Y Shang
– volume: 7
  start-page: 271
  year: 2016
  ident: 2328_CR22
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2016.00271
  contributor:
    fullname: SA Sulaiman
– volume: 41
  start-page: 199
  issue: 3
  year: 2021
  ident: 2328_CR7
  publication-title: Cancer Commun
  doi: 10.1002/cac2.12138
  contributor:
    fullname: G Pan
– volume: 5
  start-page: 115
  issue: 3
  year: 2008
  ident: 2328_CR41
  publication-title: RNA Biol
  doi: 10.4161/rna.5.3.6558
  contributor:
    fullname: M Korpal
– volume: 100
  start-page: 134
  year: 2009
  ident: 2328_CR11
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6604794
  contributor:
    fullname: M Colomiere
– volume: 137
  start-page: 415
  year: 2011
  ident: 2328_CR39
  publication-title: J Cancer Res Clin Oncol
  doi: 10.1007/s00432-010-0898-4
  contributor:
    fullname: T Wong
– volume: 7
  start-page: 2090
  year: 2008
  ident: 2328_CR15
  publication-title: Cell Cycle
  doi: 10.4161/cc.7.14.6324
  contributor:
    fullname: M Yang
– volume: 23
  start-page: 673
  year: 2010
  ident: 2328_CR19
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.2010.49
  contributor:
    fullname: A Mahajan
– volume: 2015
  start-page: 851
  year: 1852
  ident: 2328_CR30
  publication-title: Biochim. Biophys. Acta Mol. Basis Dis.
  contributor:
    fullname: C Tsai
– volume: 76
  start-page: 453
  issue: 3
  year: 2019
  ident: 2328_CR26
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-018-2941-6
  contributor:
    fullname: W Yang
– volume: 45
  start-page: 777
  year: 2012
  ident: 2328_CR34
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2012.01.015
  contributor:
    fullname: M Rokavec
– volume: 359
  start-page: 107
  year: 2015
  ident: 2328_CR14
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2015.01.010
  contributor:
    fullname: JV Joseph
– volume: 40
  start-page: 1171
  year: 2011
  ident: 2328_CR3
  publication-title: Int J Oncol
  contributor:
    fullname: Y Yuan
– volume: 18
  start-page: 108
  year: 2020
  ident: 2328_CR40
  publication-title: Cell Commun Signal
  doi: 10.1186/s12964-020-00562-5
  contributor:
    fullname: Q Li
– volume: 22
  start-page: 407
  year: 2021
  ident: 2328_CR17
  publication-title: Asian Pacific J Cancer Prev: APJCP
  doi: 10.31557/APJCP.2021.22.2.407
  contributor:
    fullname: N Mahmood
– volume: 315
  start-page: 1576
  year: 2007
  ident: 2328_CR33
  publication-title: Science
  doi: 10.1126/science.1137999
  contributor:
    fullname: C Mayr
– volume: 12
  start-page: 1169
  year: 2011
  ident: 2328_CR2
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(11)70123-1
  contributor:
    fullname: SL Cooke
– volume: 8
  year: 2013
  ident: 2328_CR35
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0077249
  contributor:
    fullname: M Garg
– volume: 37
  start-page: 7515
  year: 2016
  ident: 2328_CR20
  publication-title: Tumor Biology
  doi: 10.1007/s13277-015-4625-2
  contributor:
    fullname: Z Shi
– volume: 7
  start-page: 289
  year: 2014
  ident: 2328_CR21
  publication-title: Asian Pacific J Trop Med
  doi: 10.1016/S1995-7645(14)60040-7
  contributor:
    fullname: Y Xi
– volume: 32
  start-page: 5272
  year: 2013
  ident: 2328_CR18
  publication-title: Oncogene
  doi: 10.1038/onc.2012.573
  contributor:
    fullname: L Guo
– volume: 24
  start-page: 244
  year: 2022
  ident: 2328_CR32
  publication-title: HPB
  doi: 10.1016/j.hpb.2021.06.421
  contributor:
    fullname: M Canale
– volume: 8
  start-page: 8859
  year: 2018
  ident: 2328_CR4
  publication-title: Sci Rep
  doi: 10.1038/s41598-018-27184-9
  contributor:
    fullname: J Gyamfi
– volume: 171
  start-page: 21
  year: 2017
  ident: 2328_CR24
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2017.01.005
  contributor:
    fullname: CX Huang
– volume: 125
  year: 2020
  ident: 2328_CR38
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2020.110037
  contributor:
    fullname: J Kozak
– volume: 71
  start-page: 209
  issue: 2021
  year: 2020
  ident: 2328_CR1
  publication-title: Cancer J. Clin.
  contributor:
    fullname: H Sung
– volume: 36
  start-page: 4843
  year: 2015
  ident: 2328_CR29
  publication-title: Tumor Biology
  doi: 10.1007/s13277-015-3138-3
  contributor:
    fullname: Y Gao
– volume: 14
  start-page: 352
  year: 2013
  ident: 2328_CR28
  publication-title: BMC Genomics
  doi: 10.1186/1471-2164-14-352
  contributor:
    fullname: L Kang
– volume: 86
  start-page: 568
  issue: Pt 2
  year: 2022
  ident: 2328_CR9
  publication-title: Semin Cancer Biol
  doi: 10.1016/j.semcancer.2022.03.028
  contributor:
    fullname: S Bose
– volume: 6
  year: 2011
  ident: 2328_CR12
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0023752
  contributor:
    fullname: Z Cheng
– start-page: 137
  volume-title: The role of interleukin (IL)-6/IL-6 receptor axis in cancer, cytokine and chemokine networks in cancer
  year: 2023
  ident: 2328_CR10
  contributor:
    fullname: MA Mir
– volume: 7
  start-page: 10
  issue: 1
  year: 2008
  ident: 2328_CR36
  publication-title: Cancer Biol Ther
  doi: 10.4161/cbt.7.1.5458
  contributor:
    fullname: HL Kim
– volume: 31
  start-page: 1891
  year: 2014
  ident: 2328_CR13
  publication-title: Oncol Rep
  doi: 10.3892/or.2014.3022
  contributor:
    fullname: Z Cheng
– volume: 9
  start-page: 430
  year: 2010
  ident: 2328_CR37
  publication-title: J Proteome Res
  doi: 10.1021/pr9007927
  contributor:
    fullname: CL Nilsson
– volume: 894
  year: 2021
  ident: 2328_CR6
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2020.173817
  contributor:
    fullname: S Xu
– volume: 233
  start-page: 3729
  year: 2018
  ident: 2328_CR16
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.26116
  contributor:
    fullname: M Zare
– volume: 61
  start-page: 672
  year: 2014
  ident: 2328_CR31
  publication-title: Neoplasma
  doi: 10.4149/neo_2014_082
  contributor:
    fullname: Y Yan
– volume: 229
  start-page: 1511
  issue: 10
  year: 2014
  ident: 2328_CR27
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.24593
  contributor:
    fullname: F Shan
– volume: 2023
  start-page: 1
  year: 2023
  ident: 2328_CR5
  publication-title: Anal Cell Pathol
  doi: 10.1155/2023/8334881
  contributor:
    fullname: T Zhang
– volume: 91
  start-page: 1355
  year: 2013
  ident: 2328_CR8
  publication-title: J Mol Med
  doi: 10.1007/s00109-013-1080-7
  contributor:
    fullname: A Macciò
– volume: 22
  start-page: 8334
  issue: 15
  year: 2021
  ident: 2328_CR23
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms22158334
  contributor:
    fullname: A Abaurrea
SSID ssj0021529
Score 2.420198
Snippet Interleukin-6 (IL-6) and hypoxia-inducible factor-1α (HIF-1α) play important roles in epithelial-mesenchymal transformation (EMT) and tumor development....
SourceID proquest
crossref
pubmed
springer
SourceType Aggregation Database
Index Database
Publisher
StartPage 155
SubjectTerms Animals
Carcinoma, Ovarian Epithelial - genetics
Carcinoma, Ovarian Epithelial - metabolism
Carcinoma, Ovarian Epithelial - pathology
Cell Line, Tumor
Epithelial-Mesenchymal Transition - genetics
Female
Gene Expression Regulation, Neoplastic
Hematology
Humans
Hypoxia-Inducible Factor 1, alpha Subunit - genetics
Hypoxia-Inducible Factor 1, alpha Subunit - metabolism
Interleukin-6 - genetics
Interleukin-6 - metabolism
Internal Medicine
Medicine
Medicine & Public Health
Metastasis
Mice
Mice, Inbred BALB C
Mice, Nude
MicroRNAs
MicroRNAs - genetics
Neoplasm Invasiveness - genetics
Neoplasm Metastasis
Neoplasms, Glandular and Epithelial - genetics
Neoplasms, Glandular and Epithelial - metabolism
Neoplasms, Glandular and Epithelial - pathology
Oncology
Original Paper
Ovarian cancer
Ovarian Neoplasms - genetics
Ovarian Neoplasms - metabolism
Ovarian Neoplasms - pathology
Pathology
Signal Transduction
STAT3 Transcription Factor - genetics
STAT3 Transcription Factor - metabolism
Title IL-6 regulates epithelial ovarian cancer EMT, invasion, and metastasis by modulating Let-7c and miR-200c through the STAT3/HIF-1α pathway
URI https://link.springer.com/article/10.1007/s12032-024-02328-2
https://www.ncbi.nlm.nih.gov/pubmed/38744773
https://www.proquest.com/docview/3054668734
https://www.proquest.com/docview/3055450193
Volume 41
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NTuMwELb4kVZcVruwu3SXRUbiRq1NM7GdHCvUbvk9QCuxp8h_QZUgRW0B8Qq8DS_CMzF20lYr4MAhysETJ_I38Xz2eGYI2Y1bSRG8upGyGUugiFkWxY6hpbHCZT4DeDhtcSp6g-Twgl8s4rjDYfeZRzJM1ItYN1_rm6FJwQtihHeZrHKfDg2VeBC356ssNEhZHR3z9nP_W6BXtPKVSzRYmu4X8rmmiLRdYfqVLLlynXw6qZ3gG-Tx4JgJOq6KyLsJdTc-ruIKFYmO7nDpq0pqPJZj2jnpN-mwvFN-S6xJVWnptZsqJIST4YTqB3o9sqF8V3lJj92USVPJDM-8WhtaF_HBu6Pn_XYf_vQOuqz1_ER9IeN79fCNDLqd_n6P1SUVmEGehv0ICcoIGylpcVgKrlsaCp0C6KgQqTGZLrRxNosUWBm5QqYqTTXSFCUAl5rwnayUo9JtEirB8diA5dy6BCBSxiUcCm44T41VcYPszYY5v6kyZ-SLHMkelBxByQMoOUpvzZDI679okuNclAiRSkgaZGfejPrvnRqqdKPbIIMkEIkqNMiPCsH568Dn9pcSW5ozSBedv_8tPz8m_ousxUG9OGslW2RlOr51v5GpTPU2WW3__XfU2Q4a-gKCXd-4
link.rule.ids 315,783,787,27936,27937,41093,41535,42162,42604,52123,52246
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1fb9MwELdgSLAXBAO2jgGexBu1SHOxnTxWaFUL7R62VNpb5H9BlVg6Nd2mfYV9G74In4mzk7RCgwceojz44kT-nX0_53x3hHyMB0kZvLqRshlLoIxZFsWOoaWxwmU-A3g4bXEqxvPk6wW_aIPC6u60e-eSDCv1NtjNF_tmaFPwghjxfUye-PzqPmP-PB5utllokbI2PObvz_1pgh7wygc-0WBqRi_I85Yj0mED6kvyyFV75Oms9YK_IveTKRN01VSRdzV1Vz6w4gdqEl3e4N5XVdR4MFf0ZJb36aK6Uf6fWJ-qytJLt1bICOtFTfUdvVzaUL-r-k6nbs2kaWQWZ16vDW2r-ODd0fN8mMPn8WTEBr9-Ul_J-FbdvSbz0Un-ZczamgrMIFHDfoQEZYSNlLQ4LCXXAw2lTgF0VIrUmEyX2jibRQqsjFwpU5WmGnmKEoB7TXhDdqpl5Q4IleB4bMBybl0CECnjEg4lN5ynxqq4Rz51w1xcNakzim2SZA9KgaAUAZQCpY86JIp2GtUFLkaJEKmEpEeON804AbxXQ1VueR1kkAUiU4Ue2W8Q3LwOfHJ_KbGl30G67fzf33L4f-IfyLNxPpsW08npt7dkNw6qxtkgOSI769W1e4e0Za3fBy39DWoJ4X8
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwELagK6248GYpLGAkbtTbNH4kOVbQ0rLdFYKutJwiP1EF61Ztumj5Cfwb_gi_iXEeLbBwQByiHDxxbM9M5nPGM4PQs7jHXOnVjaTJCKMuJlkUWwKWxgibhQzg5WmLYzE6Ya9P-elPUfzlaffGJVnFNIQsTb7oLozrbgPfQuFvAvYFLhoDr6-iHRYyI7XQTv_V-8PBZtMF9imrg2X-_OSvBukSyrzkIS0Nz_AGks2Qq_MmHw_WhTrQX37L5vg_c7qJrteoFPcrMbqFrlh_G-0e1X73O-jreEIEXlZ16-0K20UI5fgEsovn57Dblh7rID5LPDiadvDMn8vwF66DpTf4zBYSMOhqtsLqAp_NTVkxzH_AE1uQRFc0s7dBkzSu6wbB3eJ30_6UdkfjIel9_4ZD7eTP8uIuOhkOpi9GpK7iQDRAQ-hHJFRqYSKZGJig46qnqFMppSpyItU6U05pa7JIUpNE1iWpTFMFyEgKCrtbeg-1_Nzb-wgn1PJYU8O5sYzSSGrLOHVcc55qI-M2et6wMl9UyTrybVrmsLw5LG9eLm8O1PsNt_NacVc5fP6YEGlCWRs93TSDygU_ivR2vi5pAHcCNqZttFdJyeZ1NJQTSBJo6TQc33b-97E8-DfyJ2j3zcthPhkfHz5E1-JSZjjpsX3UKpZr-whwUqEe16rwA2iuB1k
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=IL-6+regulates+epithelial+ovarian+cancer+EMT%2C+invasion%2C+and+metastasis+by+modulating+Let-7c+and+miR-200c+through+the+STAT3%2FHIF-1%CE%B1+pathway&rft.jtitle=Medical+oncology+%28Northwood%2C+London%2C+England%29&rft.au=Guo%2C+Qiao+Yun&rft.au=Song%2C+Jiang+Nan&rft.au=Chen%2C+Yu+Meng&rft.au=Yuan%2C+Hai+Ning&rft.date=2024-05-14&rft.pub=Springer+US&rft.eissn=1559-131X&rft.volume=41&rft.issue=6&rft_id=info:doi/10.1007%2Fs12032-024-02328-2&rft.externalDocID=10_1007_s12032_024_02328_2
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1559-131X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1559-131X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1559-131X&client=summon